NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

The real question will be where does the NICE process pick back up at.

I think there is reason for them to say another scope/matrix are needed. The previous ado not have the right indication, have incorrect statements about what is now being reviewed and is six years old.

Will they issue a new set of docs? Will those be draft or guidance? Or do they just forget that and start the meeting invite process.

Good news is that NICE is a lot more visible than RAs.